Skip to main content

INSIGHTS AND PERSPECTIVES

  • Walgreens prepping cost-savings solution for total health care (not just scripts)

    WHAT IT MEANS AND WHY IT'S IMPORTANT — Walgreens is helping to redefine what it means to be a successful retail pharmacy operator. The proof is in this new direction that Walgreens is taking — approaching employers and payers with a comprehensive, cost-lowering strategy across that company's entire health spend, not just their prescription spend.

  • Survey: Endocrinologists would prescribe Bydureon for 20% of patients

    BURLINGTON, Mass. — Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.

  • New diabetes drug launches show primary care market still strong

    WHAT IT MEANS AND WHY IT'S IMPORTANT — For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

    (THE NEWS: FDA approves Bydureon. For the full story, click here.)

  • Women with diabetes may be at risk for hearing loss, research finds

    DETROIT — Female diabetes patients may experience a greater degree of hearing loss as they get older, particularly if their condition is not well-controlled by medication, according to a new study conducted at Henry Ford Hospital in Detroit.

  • Study: Link between diabetes drugs, pancreatic cancer risk unclear

    NEW YORK — A new study published in the American Journal of Gastroenterology examined the possible link between pancreatic cancer and drugs designed to treat diabetes, and found the association to be unclear.

    Researchers conducted a case-control study based on the British-based General Practice Research Database, which included drug prescriptions, diagnostics, hospitalizations and fatality information. The researchers also took into consideration such factors as body mass index, smoking, alcohol consumption and diabetes duration.

  • SymphonyIRI breaks down the digital consumer with new analysis

    CHICAGO — SymphonyIRI Group on Tuesday unveiled its latest segmentation solution called DigitaLink, which leverages SymphonyIRI’s Consumer Network Panel, MarketPulse research and analytic capabilities to segment shoppers into unique profiles, enabling suppliers and retailers to better manage marketing efforts with online consumers.

  • For every $1 spent on OTCs, the healthcare system saves up to $7

    WASHINGTON — For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

  • Single-cup coffee category continues to have audience, Mintel finds

    CHICAGO — Seventeen percent of coffee drinkers enjoy consuming one "cup of joe" at a time, according to new Mintel research.

X
This ad will auto-close in 10 seconds